The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
. Plasma levels of soluble CD14 independently predict mortality in HIV infection.
Open accessAbstract
BACKGROUND: Chronic human immunodeficiency virus (HIV) infection is associated with intestinal permeability and microbial translocation that contributes to systemic immune activation, which is an independent predictor of HIV disease progression. The association of microbial translocation with clinical outcome remains unknown. METHODS: This nested case-control study included 74 subjects who died, 120 of whom developed cardiovascular disease and 81 of whom developed AIDS during the Strategies for Management of Anti-Retroviral Therapy (SMART) study with matched control subjects. Intestinal fatty acid binding protein (I-FABP), lipopolysaccharide (LPS), soluble CD14 (sCD14), endotoxin core antibody (EndoCAb), and 16S ribosomal DNA (rDNA) were measured in baseline plasma samples. RESULTS: Subjects with the highest quartile of sCD14 levels had a 6-fold higher risk of death than did those in the lowest quartile (95% confidence interval, 2.2-16.1; P<.001), with minimal change after adjustment for inflammatory markers, CD4(+) T cell count, and HIV RNA level. No other marker was significantly associated with clinical outcomes. I-FABP, LPS, and sCD14 were increased and EndoCAb was decreased in study subjects, compared with healthy volunteers. sCD14 level correlated with levels of IL-6, C-reactive protein, serum amyloid A and D-dimer. CONCLUSIONS: sCD14, a marker of monocyte response to LPS, is an independent predictor of mortality in HIV infection. Therapeutic attenuation of innate immune activation may improve survival in patients with HIV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, as among those without HIV infection, a likely driving force behind this vulnerability to injury is chronic inflammation (67–69).”
From HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group (2012) · cites this paper as [69]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Self-citationCD4+ Count–Guided Interruption of Antiretroviral Treatment
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250
Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M. C., Haase, A. T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040874 · Cited by 1,836
Self-citation. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Self-citationVeazey, R. S., DeMaria, M. A., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., & Lackner, A. A. (1998) · Science · doi:10.1126/science.280.5362.427 · Cited by 1,404
LPS, TLR4 and infectious disease diversity
Miller, S., Ernst, R. K., & Bader, M. W. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1068 · Cited by 1,059
Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B. M., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314660 · Cited by 1,032
Hunt, P. W., Martin, J. N., Sinclair, E., Bredt, B. M., Hagos, E., Lampiris, H. W., & Deeks, S. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374786 · Cited by 852
Self-citationDeeks, S. G., Ramirez, C. M., Liu, L., Guo, H., Gascon, R., Narváez, A. B., Hunt, P. W., Martin, J. N., Kahn, J. S., Levy, J. A., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3333 · Cited by 803
Self-citationJiang, W., Lederman, M. M., Hunt, P. W., Sieg, S. F., Haley, K. P., Rodriguez, B. A., LANDAY, A. L., Martin, J. N., Sinclair, E., Asher, A. I., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597476 · Cited by 598
Self-citationDirectly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans
Hellerstein, M. K., Hanley, M. B., Cesar, D., Siler, S., Papageorgopoulos, C., Wieder, E., Schmidt, D. J., Hoh, R., Neese, R. A., Macallan, D. C., et al. (1999) · Nature Medicine · doi:10.1038/4772 · Cited by 592
Self-citationEnteropathy Associated with the Acquired Immunodeficiency Syndrome
Kotler, D. P., GAETZ, H. P., LANGE, M., KLEIN, E. B., & HOLT, P. R. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-4-421 · Cited by 590
HIV disease: fallout from a mucosal catastrophe?
Brenchley, J. M., Price, D. A., & Douek, D. C. (2006) · Nature Immunology · doi:10.1038/ni1316 · Cited by 579
Self-citationLiu, Z., Cumberland, W. G., Hultin, L. E., Prince, H. E., Detels, R., & Giorgi, J. V. (1997) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199710010-00003 · Cited by 547
Hazenberg, M. D., Stuart, J. W. T. C., Otto, S. A., Borleffs, J. C. C., Boucher, C. A., de Boer, R. J., Miedema, F. F., & Hamann, D. (2000) · Blood · doi:10.1182/blood.v95.1.249 · Cited by 452
Pelsers, M. M. A. L., Namiot, Z., Kisielewski, W., Namiot, A., Januszkiewicz, M., Hermens, W. T., & Glatz, J. F. C. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(03)00096-1 · Cited by 377
Initial responses to endotoxins and Gram-negative bacteria
Heumann, D., & Roger, T. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00180-8 · Cited by 359
Predictive Value of Plasma HIV RNA Level on Rate of CD4 T-Cell Decline in Untreated HIV Infection
Rodriguez, B. A., Sethi, A. K., Cheruvu, V. K., Mackay, W., Bosch, R. J., Kitahata, M. M., Boswell, S., Mathews, W. C., Bangsberg, D. R., Martin, J. N., et al. (2006) · JAMA · doi:10.1001/jama.296.12.1498 · Cited by 318
Self-citationMarchetti, G. C., Bellistrì, G. M., Borghi, E., Tincati, C., Ferramosca, S., Francesca, M. L., Morace, G., Gori, A., & Monforte, A. D. (2008) · AIDS · doi:10.1097/qad.0b013e3283112d29 · Cited by 296
Lahiri, D. K., & Schnabel, B. (1993) · Biochemical Genetics · doi:10.1007/bf02401826 · Cited by 288
Phillips, A. N., Carr, A. D., Neuhaus, J., Visnegarwala, F., Prineas, R. J., Burman, W. J., Williams, I. G., Drummond, F., Duprez, D. A., Belloso, W. H., et al. (2008) · Antiviral Therapy · doi:10.1177/135965350801300215 · Cited by 240
Human monocyte CD14 is upregulated by lipopolysaccharide
Landmann, R., Knopf, H. P., Link, S., Sansano, S., Schumann, R., & Zimmerli, W. (1996) · Infection and Immunity · doi:10.1128/iai.64.5.1762-1769.1996 · Cited by 234
Lahiri, D. K., & Schnabel, B. (1993) · Biochemical Genetics · doi:10.1007/bf00553174 · Cited by 201
Kitchens, R. L., Thompson, P. A., Viriyakosol, S., O’Keefe, G. E., & Munford, R. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13139 · Cited by 199
Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14
Hailman, E., Vasselon, T., Kelley, M. A., Busse, L. A., Hu, M. C. ‐., Lichenstein, H. S., Detmers, P. A., & Wright, S. D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.11.4384 · Cited by 197
Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells
Gioannini, T. L., & Weiss, J. P. (2007) · Immunologic Research · doi:10.1007/s12026-007-0069-0 · Cited by 195
Kitchens, R. L., Thompson, P. A., Viriyakosol, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113139 · Cited by 172
Rodger, A., Fox, Z. V., Lundgren, J. D., Kuller, L. H., Boesecke, C., Gey, D., Skoutelis, A., Goetz, M. B., Phillips, A. N., & the INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2009) · The Journal of Infectious Diseases · doi:10.1086/605447 · Cited by 164
Wallet, M. A., Rodriguez, C. A., Yin, L., Saporta, S., Chinratanapisit, S., Hou, W., Sleasman, J. W., & Goodenow, M. M. (2010) · AIDS · doi:10.1097/qad.0b013e328339e228 · Cited by 153
Roles for accessory molecules in microbial recognition by Toll-like receptors
Miyake, K. (2006) · Journal of Endotoxin Research · doi:10.1179/096805106x118807 · Cited by 150
Li, Q., Estes, J. D., Duan, L., Jessurun, J., Pambuccian, S. E., Forster, C. L., Wietgrefe, S. W., Zupancic, M., Schacker, T. W., Reilly, C., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/525046 · Cited by 131
Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans
Talwar, S., Munson, P. J., Barb, J. J., Fiuza, C., Cintron, A. D. P., Logun, C., Tropea, M., Khan, S. S., Reda, D., Shelhamer, J. H., et al. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00192.2005 · Cited by 131
Cytokines and cytokine therapies in HIV infection.
Valdez, H., & Lederman, M. M. (1997) · PubMed · Cited by 127
Rajasuriar, R., Booth, D. R., Solomon, A. E., Chua, K., Spelman, T. D., Gouillou, M., Schlub, T. E., Davenport, M. P., Crowe, S. M., Elliott, J., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/656369 · Cited by 116
Self-citationLipoprotein particle subclasses, cardiovascular disease and HIV infection
Duprez, D. A., Kuller, L. H., Tracy, R. P., Otvos, J. D., Cooper, D. A., Hoy, J., Neuhaus, J., Paton, N. I., Friis‐Møller, N., Lampe, F. C., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.001 · Cited by 111
Self-citationHenckaerts, L., Nielsen, K. R., Steffensen, R., Steen, K. V., Mathieu, C., Giulietti, A., Wouters, P. J., Milants, I., Vanhorebeek, I., Langouche, L., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819263d8 · Cited by 106
Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm
Ford, E. S., Puronen, C. E., & Sereti, I. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328329c68c · Cited by 70
Self-citationThe immune response to AIDS virus infection: good, bad, or both?
Deeks, S. G., & Walker, B. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21318 · Cited by 69
Self-citationHiki, N., Berger, D., Prigl, C., Boelke, E., Wiedeck, H., Seidelmann, M., Staib, L., Kaminishi, M., Oohara, T., & Beger, H. G. (1998) · Infection and Immunity · doi:10.1128/iai.66.3.1135-1141.1998 · Cited by 63
The immune response to AIDS virus infection: good, bad, or both?
Deeks, S. G., & Walker, B. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421318 · Cited by 63
Self-citationAssociation of Soluble Endotoxin Receptor CD14 and Mortality Among Patients Undergoing Hemodialysis
Raj, D. S., Shah, V. O., Rambod, M., Kovesdy, C. P., & Kalantar‐Zadeh, K. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.06.028 · Cited by 57
Chylomicrons can inhibit endotoxin activity in vitro
Eichbaum, E. B., Harris, H. W., Kane, J. P., & Rapp, J. H. (1991) · Journal of Surgical Research · doi:10.1016/0022-4804(91)90143-a · Cited by 52
Increased levels of circulating soluble CD14 in Kawasaki disease
Takeshita, S., Nakatani, K., Tsujimoto, H., Kawamura, Y., Kawase, H., & Sekine, I. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01120.x · Cited by 49
Wilson, C. M., Ellenberg, J. H., Douglas, S. D., Moscicki, A., Holland, C. A., & For The Reach Project Of The Adoles (2004) · AIDS Research and Human Retroviruses · doi:10.1089/088922204322996482 · Cited by 46
Franco, J. C., González‐Quintela, A., Quinteiro, C., Gudé, F., Perez, L., Torre, J., & Vidal, C. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000171977.25531.7a · Cited by 45
Meiler, C. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i38.6031 · Cited by 45
Cross, A. S., Opal, S. M., Warren, H. S., Palardy, J. E., Glaser, K., Parejo, N. A., & Bhattacharjee, A. K. (2001) · The Journal of Infectious Diseases · doi:10.1086/319297 · Cited by 43
Mucosal Plasma Cell Repertoire During HIV-1 Infection
Scamurra, R. W., Nelson, D. B., Lin, X. M., Miller, D. J., Silverman, G. J., Kappel, T., Thurn, J. R., Lorenz, E., Kulkarni, A. P., & Janoff, E. N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.4008 · Cited by 34
Scuderi, F., Convertino, R., Molino, N., Provenzano, C., Marino, M., Zoli, A., & Bartoccioni, E. (2003) · Autoimmunity · doi:10.1080/0891693031000079275 · Cited by 31
Jirillo, E., Amati, L., Caradonna, L., Greco, B. M., Cozzolongo, R., Cuppone, R., Piazzolla, G., Caccavo, D., Antonaci, S., & Manghisi, O. G. (1998) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923979809034805 · Cited by 29
Assay of Endotoxin by LimulusAmebocyte Lysate
Ketchum, P. A., & Novitsky, T. J. (2003) · Humana Press eBooks · doi:10.1385/1-59259-216-3:3 · Cited by 21
A CD14 Domain with Lipopolysaccharide‐Binding and ‐Neutralizing Activity
Voss, S., Welte, S., Fotin‐Mleczek, M., Fischer, R., Ulmer, A. J., Jung, G., Wiesmüller, K., & Brock, R. E. (2006) · ChemBioChem · doi:10.1002/cbic.200500257 · Cited by 13
Kudlová, M., Kunes, P., Koláčková, M., Lonský, V., Manďák, J., Andrýs, C., Jankovičová, K., & Krejsek, J. (2007) · Mediators of Inflammation · doi:10.1155/2007/72356 · Cited by 9
Cited by
Sorted by citations
Murray, D. D., Suzuki, K., Law, M. G., Trebicka, J., Neuhaus, J., Wentworth, D. N., Johnson, M. A., Vjecha, M. J., Kelleher, A. D., Emery, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139981 · Cited by 2,740
Self-citationThe end of AIDS: HIV infection as a chronic disease
Deeks, S. G., Lewin, S. R., & Havlir, D. V. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61809-7 · Cited by 2,081
Self-citationThevaranjan, N., Puchta, A., Schulz, C., Naidoo, A., Szamosi, J. C., Verschoor, C. P., Loukov, D., Schenck, L. P., Jury, J., Foley, K. P., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.03.002 · Cited by 1,322
Systemic Effects of Inflammation on Health during Chronic HIV Infection
Deeks, S. G., Tracy, R. P., & Douek, D. C. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.001 · Cited by 910
Self-citationNational Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
Metadata
- Authors
- Sandler, N. G., Wand, H., Roque, A., Law, M., Nason, M. C., Nixon, D. E., Pedersen, C., Ruxrungtham, K., Lewin, S. R., Emery, S., Neaton, J. D., Brenchley, J. M., Deeks, S. G., Sereti, I., & Douek, D. C.
- Affiliations
- UNSW Sydney (AU)
- National Institutes of Health (US)
- Virginia Commonwealth University (US)
- University of Southern Denmark (DK)
- Chulalongkorn University (TH)
- Burnet Institute (AU)
- University of Minnesota (US)
- San Francisco General Hospital (US)
- ORCID
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03-15
- Volume
- 203
- Issue
- 6
- Pages
- 780-790
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- PMC
- PMC3071127
- OpenAlex
- W2098152094
- Cited by
- 1,106
- References
- 50
- Citations by year
- 2026: 32 · 2025: 31 · 2024: 59 · 2023: 48 · 2022: 67 · 2021: 70 · 2020: 76 · 2019: 70 · 2018: 69 · 2017: 83 · 2016: 107 · 2015: 97 · 2014: 111 · 2013: 93 · 2012: 65
- FWCI
- 37.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- National Center for Genetic Engineering and Biotechnology
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (AI 76174, P01AI076174)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- soluble CD14, HIV infection, mortality prediction, microbial translocation, intestinal permeability, lipopolysaccharide, endotoxin core antibody, intestinal fatty acid binding protein, cardiovascular disease, AIDS, innate immune activation, SMART trial, prognostic factors
- MeSH terms
- Adult, Cause of Death, Humans, Lipopolysaccharides, Male, Middle Aged, RNA, Viral, Biomarkers, CD4-Positive T-Lymphocytes, HIV Infections, Logistic Models, Case-Control Studies, Lipopolysaccharide Receptors, Fatty Acid-Binding Proteins, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review